U.S. Online Retail and Ecommerce Stock News

NVR (NVR) stock is back in focus after first quarter 2026 results showed lower profit and revenue, weaker homebuilding margins, and a drop in settlements, with earnings missing analyst expectations and pressuring sentiment. See our latest analysis for NVR. The weaker first quarter results and earnings miss have gone hand in hand with a 23.66% 90 day share price return decline and a 16.17% fall in 1 year total shareholder return, suggesting momentum has cooled after a modest 3 year gain. If...

In late April 2026, Constellium SE reported first‑quarter sales of US$2.46 billion and net income of US$199 million, with earnings per share from continuing operations rising sharply year on year and record Adjusted EBITDA prompting higher full‑year 2026 guidance and a new US$300 million share repurchase program. Alongside this strong start to 2026, Constellium secured a multi‑year aluminum extrusions supply agreement with Airbus and saw mixed insider activity, combining sizeable share sales...

IMAX (IMAX) surprised the market with first quarter earnings per share above analyst expectations, even as revenue softened. The company also reaffirmed its guidance for record 2026 box office and outlined early second quarter strength. See our latest analysis for IMAX. The latest earnings beat and reaffirmed box office guidance come as the stock has cooled in the short term, with a 1-month share price return of a 12.19% decline and a year-to-date share price return of a 2.17% decline. At the...

Cisco Systems (CSCO) has drawn fresh attention after unveiling its Universal Quantum Switch, a research prototype designed to route and convert quantum information across major encoding methods at room temperature on standard telecom fiber. See our latest analysis for Cisco Systems. That quantum networking announcement comes at a time when momentum in Cisco’s stock has clearly picked up, with a 30 day share price return of 17.22% and a 1 year total shareholder return of 59.75% reinforcing a...

WSFS Financial (WSFS) just packed several shareholder focused moves into one update, pairing first quarter results with an 18% dividend increase and a sizable new share repurchase authorization that reframes the stock’s current appeal. See our latest analysis for WSFS Financial. Despite a 1 day share price decline of 1.28% to US$71.21 and a slightly weaker 7 day share price return, WSFS still carries strong momentum. The company has a 29.36% year to date share price return and a 35.84% 1 year...

Tennant (TNC) is back in focus after Q1 2026 results showed sales of US$297.9 million and non-GAAP EPS ahead of analyst expectations, alongside a larger share repurchase capacity of up to 15%. See our latest analysis for Tennant. At a share price of US$81.95, Tennant has seen a 17.34% 1 month share price return and a 10.80% year to date share price return. The 1 year total shareholder return of 16.32% points to building momentum as investors weigh Q1 earnings, the expanded buyback capacity...

Analyst Concerns and Dividend Move Put Tencent Music in Focus Recent analyst downgrades and slightly reduced fair value estimates have pushed Tencent Music Entertainment Group (TME) into the spotlight, as competition and earnings visibility stay front of mind for investors. At the same time, the company’s ordinary annual cash dividend of US$0.12 per share for 2025, with an ex dividend date of 1 April 2026, offers a degree of income continuity that some shareholders may welcome. See our latest...

In late April 2026, Nuvalent announced a multi-year collaboration with Guardant Health to use Guardant’s Infinity tissue and liquid biopsy platform to support clinical development, potential companion diagnostics, and future global commercialization of Nuvalent’s oncology pipeline. This partnership reinforces how precision diagnostics are becoming integral to drug development, tying Guardant’s testing capabilities directly to emerging targeted cancer therapies and potential regulatory...

Commvault Systems recently reported fourth-quarter 2026 revenue of US$311.69 million and full-year revenue of US$1.18 billion, issued fiscal 2027 guidance calling for US$1.30–US$1.31 billion in total revenue, completed a major share repurchase program, and expanded its Commvault Cloud platform availability to Google Cloud Marketplace. These developments, alongside growing annual recurring revenue and upcoming presentations at Google Cloud Next 2026 and the GEOINT Symposium 2026, highlight...

In April 2026, DuPont’s Corian Design business introduced its 2026 “Nature in Motion” Color Collection for solid surface and quartz, while its Liveo unit launched Pharma TPE Overmolded Assemblies designed to support ultrapure fluid transfer in pharmaceutical and biopharmaceutical manufacturing. By broadening both its design-centric surfacing portfolio and its biopharma processing solutions, DuPont is emphasizing material innovation tailored to architects, designers, and life sciences...

Q1 earnings put Pinnacle West Capital (PNW) back in focus Pinnacle West Capital (PNW) is back on investors’ radar after first quarter 2026 results showed sales of US$1,149.6 million and net income of US$32.92 million, compared with a loss in the prior year period. See our latest analysis for Pinnacle West Capital. The Q1 return to profitability and the recently affirmed quarterly dividend of US$0.91 per share have come alongside a 15.52% year to date share price return and a 44.72% three year...

Smurfit Westrock Plc recently reported past first-quarter 2026 results showing sales of US$7,712 million, broadly flat year-on-year, while net income dropped to US$65 million and earnings per share fell to US$0.12. Despite the sharp profit compression and operational challenges, the company affirmed a quarterly dividend of US$0.4523 per share and outlined mill and site closures alongside a review of its London Stock Exchange listing. We’ll now examine how the sharp drop in quarterly profit...

ICU Medical stock snapshot after recent share performance ICU Medical (ICUI) has drawn fresh attention after a weak run in the stock, with negative returns over the past week, month and past 3 months, focusing investors on how its fundamentals compare with recent price action. See our latest analysis for ICU Medical. At a share price of $118.67, ICU Medical has experienced short-term share price pressure, with a 21.25% decline over three months contributing to a 5-year total shareholder...

Deluxe (DLX) has moved into focus after announcing a partnership with MRI Software that makes it the official processing partner for MRI’s rent payment solution, expanding its role in property management payments. See our latest analysis for Deluxe. The new MRI partnership and recent technology awards come on top of strong share price momentum, with a 30-day share price return of 12.69% and a 1-year total shareholder return of 118.64%. However, the 5-year total shareholder return of a 13.84%...

Matson stock moves and recent performance snapshot Matson (MATX) has caught investor attention after recent share price moves, with the stock showing mixed short term returns but gains over the past month, past 3 months, year to date and past year. See our latest analysis for Matson. Recent trading has been choppy, with a 1 day share price return of a 1.57% decline and a 7 day share price return of a 3.34% decline. However, the 30 day and year to date share price returns of 2.67% and 38.09%...

Lazard, Inc. has already reported first‑quarter 2026 results, with net income rising to US$100.92 million and diluted EPS from continuing operations at US$0.91, alongside affirming a US$0.50 per‑share quarterly dividend and continuing a buyback program. Beyond the headline figures, the quarter highlighted a contrast between strong revenue and asset management inflows and an adjusted earnings miss versus analyst expectations, raising fresh questions about cost discipline and earnings...

On 4 May 2026, BioCryst Pharmaceuticals announced it had licensed European commercialization rights for its investigational HAE therapy navenibart to an Irish affiliate of Neopharmed Gentili in exchange for a US$70,000,000 upfront payment, up to US$275,000,000 in potential milestones, and tiered royalties of 18% to 30% on net sales. This agreement deepens BioCryst’s existing relationship with Neopharmed Gentili, uses an established European rare-disease infrastructure, and brings in fresh...

In April 2026, Regal Rexnord’s board declared a US$0.35 per share quarterly dividend payable on July 14, 2026, and also held its regular board meeting. The board simultaneously finalized a leadership transition plan, appointing Schneider Electric executive Aamir Paul as incoming CEO and director, signaling a shift in operational and growth priorities. Next, we’ll examine how bringing in Aamir Paul as CEO could influence Regal Rexnord’s investment narrative built around efficiency and...

In late April 2026, CCC Intelligent Solutions Holdings reported first‑quarter revenue of US$281.27 million and net income of US$15.42 million, raised its 2026 revenue guidance, expanded AI-driven insurance platform agreements, and announced that long‑tenured finance executive Rodney Christo will become interim CFO following Brian Herb’s planned May departure. Alongside these results, CCC rolled out new AI-enabled workflow tools like mobile invoice scanning and continued large share...

Elastic (NYSE:ESTC) has been in focus after a cluster of AI oriented product updates, including native Prometheus support, MCP Apps for security and observability, and a deep integration with Google Distributed Cloud air gapped. See our latest analysis for Elastic. Yet despite a stream of AI focused launches and new partnerships, the stock’s 1 day share price return of 4.22% and 7 day return of 5.92% sit against a 90 day share price return of 15.59% and a 1 year total shareholder return of...

Q1 earnings, guidance and BetterHelp's insurance shift Teladoc Health (TDOC) has been back in focus after Q1 2026 results and updated guidance put its BetterHelp insurance transition front and center for investors watching the virtual care stock. See our latest analysis for Teladoc Health. The stock has seen short term momentum build, with a 30 day share price return of 25.81% and a 90 day gain of 29.75%. However, the 1 year total shareholder return of 7.27% and 3 year total shareholder...

M/I Homes, Inc. reported past first-quarter 2026 results, with revenue of US$920.71 million and net income of US$67.83 million, both lower than a year earlier. The company also completed a share repurchase of 587,034 shares for US$79.65 million, reducing its share count by 2.27%, which can lift per-share metrics even as earnings soften. We’ll now examine how the weaker first-quarter earnings, alongside the ongoing buyback, affect M/I Homes’ existing investment narrative. Uncover the next big...

How Tapestry Stock Has Been Trading Recently Tapestry (TPR) has been on many investors’ radar after a mixed run in its share price, with recent daily and weekly declines but gains over the past 3 months and year. Over the past day and past week, the stock has recorded negative returns, while the past month shows a smaller decline. In contrast, performance over the past 3 months, year, 3 years, and 5 years is positive on a total return basis. This split in shorter term weakness and longer term...

Cullen/Frost Bankers, Inc. reported first‑quarter 2026 results on April 30, 2026, with net interest income rising to US$438.52 million and net income to US$170.99 million, alongside higher basic and diluted earnings per share of US$2.65. The company coupled this profit growth with a 3% increase in its common quarterly dividend to US$1.03 per share and a declared Series B preferred dividend, underscoring its ongoing focus on shareholder income alongside an expanding Texas branch...